[1]CurrentPatentAssignee:PFIZERINC-US2007/265272,2007,A1Locationinpatent:Page/Pagecolumn37;39;105
Title: Discovery of a novel class of exquisitely selective mesenchymal-epithelial transition factor (c-MET) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the treatment of cancer.
Journal: Journal of medicinal chemistry 20120927
